{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T20:57:16Z","timestamp":1779051436922,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Instituto de Salud Carlos III (ISCIII)- Fondo Europeo de Desarrollo Regional (FEDER), Ministry of Economy and Competitiveness","award":["PI18\/00643"],"award-info":[{"award-number":["PI18\/00643"]}]},{"name":"ISCIII-MINECO-AES-FEDER-FSE","award":["Miguel Servet"],"award-info":[{"award-number":["Miguel Servet"]}]},{"DOI":"10.13039\/100014440","name":"Ministry of Science, Innovation and Universities","doi-asserted-by":"crossref","award":["RTI2018-095159-B-I00"],"award-info":[{"award-number":["RTI2018-095159-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Regional Government of Madrid","award":["Program I2"],"award-info":[{"award-number":["Program I2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The biological mechanisms involved in aseptic loosening include inflammation-associated and bone resorption-associated processes. Coordinated cellular actions result in biochemical imbalances with devastating consequences for the joint. Given that this condition is not known for showing systemic signs, we investigated whether circulating levels of inflammation-related proteins are altered in patients with aseptic loosening. Our study included 37 patients who underwent revision surgery due to hip osteolysis and aseptic loosening and 31 patients who underwent primary total hip arthroplasty. Using antibody arrays, we evaluated the serum levels of 320 proteins in four patients from each group. The results showed differences in insulin-like growth factor-binding protein 1 (IGFBP-1) concentrations, which we then quantified using enzyme-linked immunosorbent assay tests in all study patients. The results confirmed that serum IGFBP-1 concentrations were higher in the revision surgery patients than in the hip arthroplasty patients. In vitro studies showed that exposure of human osteoblasts to titanium particles induced an IGFBP-1 release that further increased when exposure to particles was performed in media conditioned by human M1 macrophages. These findings suggest that elevated serum IGFBP-1 levels in patients with aseptic loosening can arise from increased local IGFBP-1 production in the inflammatory environment of the periprosthetic bed.<\/jats:p>","DOI":"10.1038\/s41598-020-79813-x","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:24:12Z","timestamp":1610479452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Wear of hip prostheses increases serum IGFBP-1 levels in patients with aseptic loosening"],"prefix":"10.1038","volume":"11","author":[{"given":"Gema","family":"Vall\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Garc\u00eda-Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Garc\u00eda-Cimbrelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Vilaboa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"79813_CR1","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/S0140-6736(07)60457-7","volume":"370","author":"ID Learmonth","year":"2007","unstructured":"Learmonth, I. D., Young, C. & Rorabeck, C. The operation of the century: Total hip replacement. Lancet 370, 1508\u20131519. https:\/\/doi.org\/10.1016\/S0140-6736(07)60457-7 (2007).","journal-title":"Lancet"},{"key":"79813_CR2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.arth.2013.01.012","volume":"28","author":"P Sadoghi","year":"2013","unstructured":"Sadoghi, P. et al. Revision surgery after total joint arthroplasty: a complication-based analysis using worldwide arthroplasty registers. J. Arthroplasty. 28, 1329\u20131332. https:\/\/doi.org\/10.1016\/j.arth.2013.01.012 (2013).","journal-title":"J. Arthroplasty."},{"key":"79813_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11999-009-0834-6","volume":"34","author":"A L\u00fcbbeke","year":"2007","unstructured":"L\u00fcbbeke, A., Katz, J. N., Perneger, T. V. & Hoffmeyer, P. Primary and revision hip arthroplasty: 5-year outcomes and influence of age and comorbidity. J. Rheumatol. 34, 394\u2013400. https:\/\/doi.org\/10.1007\/s11999-009-0834-6 (2007).","journal-title":"J. Rheumatol."},{"key":"79813_CR4","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1007\/s11999-009-0834-6","volume":"467","author":"SM Kurtz","year":"2009","unstructured":"Kurtz, S. M. et al. Future young patient demand for primary and revision joint replacement: National projections from 2010 to 2030. Clin. Orthop. Relat. Res. 467, 2606\u20132612. https:\/\/doi.org\/10.1007\/s11999-009-0834-6 (2009).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"79813_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.joca.2014.04.009","volume":"22","author":"C Pabinger","year":"2014","unstructured":"Pabinger, C. & Geissler, A. Utilization rates of hip arthroplasty in OECD countries. Osteoarthritis Cartil. 22, 734\u2013741. https:\/\/doi.org\/10.1016\/j.joca.2014.04.009 (2014).","journal-title":"Osteoarthritis Cartil."},{"key":"79813_CR6","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2106\/JBJS.H.00067","volume":"90","author":"R Iorio","year":"2008","unstructured":"Iorio, R. et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: Preparing for an epidemic. J. Bone Joint Surg. Am. 90, 1598\u20131605. https:\/\/doi.org\/10.2106\/JBJS.H.00067 (2008).","journal-title":"J. Bone Joint Surg. Am."},{"key":"79813_CR7","first-page":"182","volume":"67","author":"NJ Hallab","year":"2009","unstructured":"Hallab, N. J. & Jacobs, J. J. Biologic effects of implant debris. Bull. NYU Hosp. Jt. Dis. 67, 182\u2013188 (2009).","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"79813_CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.blo.0000238813.95035.1b","volume":"454","author":"PE Purdue","year":"2007","unstructured":"Purdue, P. E., Koulouvaris, P., Potter, H. G., Nestor, B. J. & Sculco, T. P. The cellular and molecular biology of periprosthetic osteolysis. Clin. Orthop. Relat. Res. 454, 251\u2013261 (2007).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"79813_CR9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.33549\/physiolres.931140","volume":"57","author":"J Gallo","year":"2008","unstructured":"Gallo, J., Raska, M., Mr\u00e1zek, F. & Petrek, M. Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis. Physiol. Res. 57, 339\u2013349 (2008).","journal-title":"Physiol. Res."},{"key":"79813_CR10","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1016\/j.biomaterials.2010.03.046","volume":"31","author":"SB Goodman","year":"2010","unstructured":"Goodman, S. B. & Ma, T. Cellular chemotaxis induced by wear particles from joint replacements. Biomaterials 31, 5045\u20135050. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.03.046 (2010).","journal-title":"Biomaterials"},{"key":"79813_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/BLO.0b013e31804b4147","volume":"460","author":"G Holt","year":"2007","unstructured":"Holt, G., Murnaghan, C., Reilly, J. & Meek, R. M. The biology of aseptic osteolysis. Clin. Orthop. Relat. Res. 460, 240\u2013252. https:\/\/doi.org\/10.1097\/BLO.0b013e31804b4147 (2007).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"79813_CR12","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-200800001-00010","author":"RS Tuan","year":"2008","unstructured":"Tuan, R. S. et al. What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?. J. Am. Acad. Orthop. Surg. https:\/\/doi.org\/10.5435\/00124635-200800001-00010 (2008).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"79813_CR13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1525-1594.2009.00736.x","volume":"33","author":"A Beraudi","year":"2009","unstructured":"Beraudi, A., Stea, S., Cremonini, V., Visentin, M. & Toni, A. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty. Artif. Organs 33, 538\u2013543. https:\/\/doi.org\/10.1111\/j.1525-1594.2009.00736.x (2009).","journal-title":"Artif. Organs"},{"key":"79813_CR14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2106\/JBJS.E.01038","volume":"88","author":"V Granchi","year":"2006","unstructured":"Granchi, V. et al. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis. J. Bone Jt. Surg. Am. 88, 1501\u20131509. https:\/\/doi.org\/10.2106\/JBJS.E.01038 (2006).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"79813_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/1874325001105010092","volume":"16","author":"MT Mertens","year":"2011","unstructured":"Mertens, M. T. & Singh, J. A. Biomarkers in arthroplasty: A systematic review. Open Orthop. J. 16, 92\u2013105. https:\/\/doi.org\/10.2174\/1874325001105010092 (2011).","journal-title":"Open Orthop. J."},{"key":"79813_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00590-002-0015-8","volume":"12","author":"M Repanti","year":"2002","unstructured":"Repanti, M., Stamatakis, M., Baikousis, A., Papazisis, Z. & Korovessis, P. Histologic findings of periprosthetic tissues retrieved during revision of cementless hip arthroplasties. Eur. J. Orthop. Surg. Traumatol. 12, 42\u201347. https:\/\/doi.org\/10.1007\/s00590-002-0015-8 (2002).","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"79813_CR17","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.arth.2004.03.024","volume":"19","author":"ML Wang","year":"2004","unstructured":"Wang, M. L., Sharkey, P. F. & Tuan, R. S. Particle bioreactivity and wear-mediated osteolysis. J. Arthropl. 19, 1028\u20131038. https:\/\/doi.org\/10.1016\/j.arth.2004.03.024 (2004).","journal-title":"J. Arthropl."},{"key":"79813_CR18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.actbio.2011.12.001","volume":"8","author":"G Vall\u00e9s","year":"2012","unstructured":"Vall\u00e9s, G., Garc\u00eda-Cimbrelo, E. & Vilaboa, N. Involvement of extracellular Hsp72 in wear particle-mediated osteolysis. Acta Biomater. 8, 1146\u20131155. https:\/\/doi.org\/10.1016\/j.actbio.2011.12.001 (2012).","journal-title":"Acta Biomater."},{"key":"79813_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/art.1780340502","volume":"34","author":"R Altman","year":"1991","unstructured":"Altman, R. et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 34, 505\u2013514. https:\/\/doi.org\/10.1002\/art.1780340502 (1991).","journal-title":"Arthritis Rheum."},{"key":"79813_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/jcp.2005.027458","volume":"59","author":"L Morawietz","year":"2006","unstructured":"Morawietz, L. et al. Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J. Clin. Pathol. 59, 591\u2013597. https:\/\/doi.org\/10.1136\/jcp.2005.027458 (2006).","journal-title":"J. Clin. Pathol."},{"key":"79813_CR21","first-page":"459","volume":"31","author":"WG Paprosky","year":"2002","unstructured":"Paprosky, W. G. & Burnett, R. S. Assessment and classification of bone stock deficiency in revision total hip arthroplasty. Am. J. Orthop. (Belle Mead NJ) 31, 459\u2013464 (2002).","journal-title":"Am. J. Orthop. (Belle Mead NJ)"},{"key":"79813_CR22","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1016\/j.biomaterials.2006.05.045","volume":"27","author":"G Vall\u00e9s","year":"2006","unstructured":"Vall\u00e9s, G. et al. Differential inflammatory macrophage response to rutile and titanium particles. Biomaterials 27, 5199\u20135211. https:\/\/doi.org\/10.1016\/j.biomaterials.2006.05.045 (2006).","journal-title":"Biomaterials"},{"key":"79813_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/jbm.a.31315","volume":"84","author":"G Vall\u00e9s","year":"2008","unstructured":"Vall\u00e9s, G. et al. Rutile and titanium particles differentially affect the production of osteoblastic local factors. J. Biomed. Mater. Res. A. 84, 324\u2013336. https:\/\/doi.org\/10.1002\/jbm.a.31315 (2008).","journal-title":"J. Biomed. Mater. Res. A."},{"key":"79813_CR24","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1016\/j.actbio.2012.08.027","volume":"9","author":"G Vall\u00e9s","year":"2013","unstructured":"Vall\u00e9s, G. et al. Simvastatin prevents the induction of interleukin-6 gene expression by titanium particles in human osteoblastic cells. Acta Biomater. 9, 4916\u20134925. https:\/\/doi.org\/10.1016\/j.actbio.2012.08.027 (2013).","journal-title":"Acta Biomater."},{"key":"79813_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13287-020-1578-1","volume":"11","author":"G Vall\u00e9s","year":"2020","unstructured":"Vall\u00e9s, G. et al. Influence of inflammatory conditions provided by macrophages on osteogenic ability of mesenchymal stem cells. Stem Cell Res. Ther. 11, 57. https:\/\/doi.org\/10.1186\/s13287-020-1578-1 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"79813_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13287-019-1156-6","volume":"10","author":"L Salda\u00f1a","year":"2019","unstructured":"Salda\u00f1a, L. et al. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors. Stem Cell Res. Ther. 10, 58. https:\/\/doi.org\/10.1186\/s13287-019-1156-6 (2019).","journal-title":"Stem Cell Res. Ther."},{"key":"79813_CR27","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s11999-016-4717-3","volume":"474","author":"NC Wingert","year":"2016","unstructured":"Wingert, N. C. et al. The ACS NSQIP risk calculator is a fair predictor of acute periprosthetic joint infection. Clin. Orthop. Relat. Res. 474, 1643\u20131648. https:\/\/doi.org\/10.1007\/s11999-016-4717-3 (2016).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"79813_CR28","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng, A. K. Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr. 96, 644\u2013647. https:\/\/doi.org\/10.1111\/j.1651-2227.2006.00178.x (2007).","journal-title":"Acta Paediatr."},{"key":"79813_CR29","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1302\/0301-620x.80b5.8513","volume":"80","author":"D Granchi","year":"1998","unstructured":"Granchi, D. et al. Bone-resorbing cytokines in serum of patients with aseptic loosening of hip prostheses. J. Bone Joint Surg. Br. 80, 912\u2013917. https:\/\/doi.org\/10.1302\/0301-620x.80b5.8513 (1998).","journal-title":"J. Bone Joint Surg. Br."},{"key":"79813_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/jor.22607","volume":"32","author":"RD Ross","year":"2014","unstructured":"Ross, R. D., Virdi, A. S., Liu, S., Sena, K. & Sumner, D. R. Particle-induced osteolysis is not accompanied by systemic remodeling but is reflected by systemic bone biomarkers. J. Orthop. Res. 32, 967\u2013973. https:\/\/doi.org\/10.1002\/jor.22607 (2014).","journal-title":"J. Orthop. Res."},{"key":"79813_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10875-009-9305-9","volume":"29","author":"X Flecher","year":"2009","unstructured":"Flecher, X. et al. Local and systemic activation of the mononuclear phagocyte system in aseptic loosening of total hip arthroplasty. J. Clin. Immunol. 29, 681\u2013690. https:\/\/doi.org\/10.1007\/s10875-009-9305-9 (2009).","journal-title":"J. Clin. Immunol."},{"key":"79813_CR32","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.arth.2005.03.034","volume":"20","author":"R Tanaka","year":"2005","unstructured":"Tanaka, R. et al. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J. Arthroplasty. 20, 1049\u20131054. https:\/\/doi.org\/10.1016\/j.arth.2005.03.034 (2005).","journal-title":"J. Arthroplasty."},{"key":"79813_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3892\/etm.2014.1870","volume":"8","author":"C Wang","year":"2014","unstructured":"Wang, C. et al. Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis. Exp. Ther. Med. 8, 1075\u20131080. https:\/\/doi.org\/10.3892\/etm.2014.1870 (2014).","journal-title":"Exp. Ther. Med."},{"key":"79813_CR34","doi-asserted-by":"publisher","first-page":"e89045","DOI":"10.1371\/journal.pone.0089045","volume":"21","author":"TM Randau","year":"2014","unstructured":"Randau, T. M. et al. Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening. PLoS ONE 21, e89045. https:\/\/doi.org\/10.1371\/journal.pone.0089045 (2014).","journal-title":"PLoS ONE"},{"key":"79813_CR35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5301\/hipint.5000253","volume":"25","author":"NR Lawrence","year":"2015","unstructured":"Lawrence, N. R., Jayasuriya, R. L., Gossiel, F. & Wilkinson, J. M. Diagnostic accuracy of bone turnover markers as a screening tool for aseptic loosening after total hip arthroplasty. Hip Int. 25, 525\u2013530. https:\/\/doi.org\/10.5301\/hipint.5000253 (2015).","journal-title":"Hip Int."},{"key":"79813_CR36","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jor.21082","volume":"28","author":"L Savarino","year":"2010","unstructured":"Savarino, L., Avnet, S., Greco, M., Giunti, A. & Baldini, N. Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: A cohort study. J. Orthop. Res. 28, 887\u2013892. https:\/\/doi.org\/10.1002\/jor.21082 (2010).","journal-title":"J. Orthop. Res."},{"key":"79813_CR37","first-page":"97","volume":"26","author":"MJ Seibel","year":"2005","unstructured":"Seibel, M. J. Biochemical markers of bone turnover: Part I: Biochemistry and variability. Clin. Biochem. Rev. 26, 97\u2013122 (2005).","journal-title":"Clin. Biochem. Rev."},{"key":"79813_CR38","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1007\/s11999-014-3580-3","volume":"472","author":"DR Sumner","year":"2014","unstructured":"Sumner, D. R., Ross, R. & Purdue, E. Are there biological markers for wear or corrosion? A systematic review. Clin. Orthop. Relat. Res. 472, 3728\u20133739. https:\/\/doi.org\/10.1007\/s11999-014-3580-3 (2014).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"79813_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1874325001610010241","volume":"15","author":"E Sukur","year":"2016","unstructured":"Sukur, E., Akman, Y. E., Ozturkmen, Y. & Kucukdurmaz, F. Particle disease: A current review of the biological mechanisms in periprosthetic osteolysis after hip arthroplasty. Open Orthop. J. 15, 241\u2013251. https:\/\/doi.org\/10.2174\/1874325001610010241 (2016).","journal-title":"Open Orthop. J."},{"key":"79813_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.blo.0000229365.57985.96","volume":"453","author":"Z Hundri\u0107-Haspl","year":"2006","unstructured":"Hundri\u0107-Haspl, Z., Pecina, M., Haspl, M., Tomicic, M. & Jukic, I. Plasma cytokines as markers of aseptic prosthesis loosening. Clin. Orthop. Relat. Res. 453, 299\u2013304. https:\/\/doi.org\/10.1097\/01.blo.0000229365.57985.96 (2006).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"79813_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2474-8-69","volume":"8","author":"B Bordini","year":"2007","unstructured":"Bordini, B. et al. Factors affecting aseptic loosening of 4750 total hip arthroplasties: Multivariate survival analysis. BMC Musculoskelet. Disord. 8, 69. https:\/\/doi.org\/10.1186\/1471-2474-8-69 (2007).","journal-title":"BMC Musculoskelet. Disord."},{"key":"79813_CR42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.arth.2010.05.014","volume":"26","author":"CA Engh","year":"2011","unstructured":"Engh, C. A. et al. Osteolysis propensity among bilateral total hip arthroplasty patients. J. Arthroplasty. 26, 555\u2013561. https:\/\/doi.org\/10.1016\/j.arth.2010.05.014 (2011).","journal-title":"J. Arthroplasty."},{"key":"79813_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1874467211205020143","volume":"5","author":"KE Govoni","year":"2012","unstructured":"Govoni, K. E. Insulin-like growth factor-I molecular pathways in osteoblasts: Potential targets for pharmacological manipulation. Curr. Mol. Pharmacol. 5, 143\u2013152 (2012).","journal-title":"Curr. Mol. Pharmacol."},{"key":"79813_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/s0953-6205(02)00183-8","volume":"14","author":"PM Jehle","year":"2003","unstructured":"Jehle, P. M. et al. Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients. Eur. J. Intern Med. 14, 32\u201338. https:\/\/doi.org\/10.1016\/s0953-6205(02)00183-8 (2003).","journal-title":"Eur. J. Intern Med."},{"key":"79813_CR45","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cmet.2015.09.010","volume":"22","author":"X Wang","year":"2015","unstructured":"Wang, X., Wei, W., Krzeszinski, J. Y., Wang, Y. & Wan, Y. A liver-bone endocrine relay by IGFBP1 promotes osteoclastogenesis and mediates FGF21-induced bone resorption. Cell Metab. 22, 811\u2013824. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.010 (2015).","journal-title":"Cell Metab."},{"key":"79813_CR46","first-page":"221","volume":"18","author":"TF Li","year":"2000","unstructured":"Li, T. F. et al. Distribution of fibronectins and their integrin receptors in interface tissue from aseptic loosening of hip prostheses. Clin. Exp. Rheumatol. 18, 221\u2013225 (2000).","journal-title":"Clin. Exp. Rheumatol."},{"key":"79813_CR47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00223-016-0152-4","volume":"99","author":"H Lundin","year":"2016","unstructured":"Lundin, H. et al. High Serum insulin-like growth factor-binding protein 1 (IGFBP-1) is associated with high fracture risk independent of insulin-like growth factor 1 (IGF-I). Calcif. Tissue Int. 99, 333\u2013339. https:\/\/doi.org\/10.1007\/s00223-016-0152-4 (2016).","journal-title":"Calcif. Tissue Int."},{"key":"79813_CR48","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.clinbiochem.2009.05.005","volume":"42","author":"A Borai","year":"2009","unstructured":"Borai, A. et al. Biological variation in fasting serum insulin-like growth factor binding protein-1 (IGFBP-1) among individuals with a varying glucose tolerance. Clin. Biochem. 42, 1270\u20131274. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.05.005 (2009).","journal-title":"Clin. Biochem."},{"key":"79813_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tem.2009.01.002","volume":"20","author":"SB Wheatcroft","year":"2009","unstructured":"Wheatcroft, S. B. & Kearney, M. T. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: Implications for metabolic homeostasis. Trends Endocrinol. Metab. 20, 153\u2013162. https:\/\/doi.org\/10.1016\/j.tem.2009.01.002 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"79813_CR50","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1210\/jcem.80.11.7593430","volume":"80","author":"H Yki-J\u00e4rvinen","year":"1995","unstructured":"Yki-J\u00e4rvinen, H., M\u00e4kimattila, S., Utriainen, T. & Rutanen, E. M. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J. Clin. Endocrinol. Metab. 80, 3227\u20133332. https:\/\/doi.org\/10.1210\/jcem.80.11.7593430 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"79813_CR51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00223-011-9484-2","volume":"88","author":"SR Pye","year":"2011","unstructured":"Pye, S. R. et al. Influence of insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 on bone health: Results from the European Male Ageing Study. Calcif. Tissue Int. 88, 503\u2013510. https:\/\/doi.org\/10.1007\/s00223-011-9484-2 (2011).","journal-title":"Calcif. Tissue Int."},{"key":"79813_CR52","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1210\/jcem.77.5.7521340","volume":"77","author":"EM Rutanen","year":"1993","unstructured":"Rutanen, E. M., K\u00e4rkk\u00e4inen, T., Stenman, U. H. & Yki-J\u00e4rvinen, H. Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J. Clin. Endocrinol. Metab. 77, 1152\u20131155. https:\/\/doi.org\/10.1210\/jcem.77.5.7521340 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"79813_CR53","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1210\/endo.137.8.8754754","volume":"137","author":"CA Conover","year":"1996","unstructured":"Conover, C. A., Lee, P. D., Riggs, B. L. & Powell, D. R. Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: Regulation by insulin and glucocorticoid. Endocrinology 137, 3295\u20133301. https:\/\/doi.org\/10.1210\/endo.137.8.8754754 (1996).","journal-title":"Endocrinology"},{"key":"79813_CR54","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.biomaterials.2008.02.011","volume":"29","author":"G Vall\u00e9s","year":"2008","unstructured":"Vall\u00e9s, G., Gil-Garay, E., Munuera, L. & Vilaboa, N. Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles. Biomaterials 29, 2326\u20132335. https:\/\/doi.org\/10.1016\/j.biomaterials.2008.02.011 (2008).","journal-title":"Biomaterials"},{"key":"79813_CR55","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.actbio.2009.10.033","volume":"6","author":"L Salda\u00f1a","year":"2010","unstructured":"Salda\u00f1a, L. & Vilaboa, N. Effects of micrometric titanium particles on osteoblast attachment and cytoskeleton architecture. Acta Biomater. 6, 1649\u20131660. https:\/\/doi.org\/10.1016\/j.actbio.2009.10.033 (2010).","journal-title":"Acta Biomater."},{"key":"79813_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1055\/s-2007-978721","volume":"31","author":"CA Benbassat","year":"1999","unstructured":"Benbassat, C. A. et al. Interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro. Horm. Metab. Res. 31, 209\u2013215. https:\/\/doi.org\/10.1055\/s-2007-978721 (1999).","journal-title":"Horm. Metab. Res."},{"key":"79813_CR57","doi-asserted-by":"publisher","first-page":"E612","DOI":"10.1152\/ajpendo.00289.2015","volume":"310","author":"L Shi","year":"2016","unstructured":"Shi, L. et al. Direct regulation of IGF-binding protein 1 promoter by interleukin-1\u03b2 via an insulin- and FoxO-1-independent mechanism. Am. J. Physiol. Endocrinol. Metab. 310, E612\u2013E623. https:\/\/doi.org\/10.1152\/ajpendo.00289.2015 (2016).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"79813_CR58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1309\/LM4O4L0HHUTWWUDD","volume":"40","author":"FH Wians","year":"2009","unstructured":"Wians, F. H. Clinical laboratory tests: Which, why, and what do the results mean?. Lab. Med. 40, 105\u2013113. https:\/\/doi.org\/10.1309\/LM4O4L0HHUTWWUDD (2009).","journal-title":"Lab. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79813-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79813-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79813-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:35:13Z","timestamp":1670031313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79813-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["79813"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79813-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"576"}}